Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Aluminum – calcium or magnesium element – or compound containing
Patent
1997-04-25
2000-07-25
Pak, John
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Aluminum, calcium or magnesium element, or compound containing
424617, 424661, 424667, 424673, 424677, 424682, 424697, 424703, 424718, 424722, A61K 3306, A61K 3300, A61K 3304, A61K 3324
Patent
active
060934239
ABSTRACT:
A chemical agent for use in binding to and insolubilizing the solubilized products of fat digestion in order to prevent absorption of fat from the diet.
REFERENCES:
patent: 4325975 (1982-04-01), Lindon et al.
patent: 4447417 (1984-05-01), Spickett et al.
patent: 4780307 (1988-10-01), Ben-Sasson
Lapre, John A. et al., "The Antiproliferative Effect of Dietary Calcium on Colonic Epithelium . . . " Cancer Research, vol. 53(4), Feb. 15, 1993, pp. 784-789.
Chemical Abstracts 63:75396 (1965).
Kappa Pharmaceuticals Limited
Pak John
LandOfFree
Reduced absorption of fatty acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduced absorption of fatty acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduced absorption of fatty acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1334865